HIM
AMRI

Hillsdale Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Hillsdale Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,600
Closed -$42K – 601
2014
Q4 		$42K Buy
+2,600
New +$47.7K 0.01% 448
2014
Q1 		– Sell
-5,650
Closed -$57K – 603
2013
Q4 		$57K Sell
5,650
-20,950
-79% -$253K 0.02% 430
2013
Q3 		$343K Hold
26,600
– – 0.1% 155
2013
Q2 		$316K Buy
+26,600
New +$288K 0.1% 162

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Hillsdale Investment Management's AMRI Position: Q1 2015 in Review

Hillsdale Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 2,600 shares — an estimated $42K sold.

Hillsdale Investment Management first reported a position in AMRI in Q2 2013 and held it in 4 quarters. The position peaked at $343K in Q3 2013. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • Hillsdale Investment Management reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • Hillsdale Investment Management sold 2,600 Albany Molecular Research Inc shares in Q1 2015, an estimated $42K.
  • Hillsdale Investment Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 4 quarters.
  • Hillsdale Investment Management's Albany Molecular Research Inc position peaked at $343K in Q3 2013.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Hillsdale Investment Management's 13F filing for Q1 2015, filed 12 May 2015.